Concepedia

Publication | Closed Access

Adherence and Acceptability of Once Daily Lamivudine and Abacavir in Human Immunodeficiency Virus Type-1 Infected Children

DOI

34

Citations

19

References

2006

Year

Marthe Le Prevost, Hannah Green, J. Norman Flynn, Stephen Head, Margaret Clapson, Hermione Lyall, Vas Novelli, Laura Farrelly, A Sarah Walker, David M. Burger,
The Pediatric Infectious Disease Journal

Abstract

Adherence to once daily abacavir/lamivudine was good with no evidence of an association between nonadherence and virologic rebound. Acceptability of once daily drugs was best when the whole regimen was dosed once daily.

References

YearCitations

Page 1